Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10438903rdf:typepubmed:Citationlld:pubmed
pubmed-article:10438903lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:10438903lifeskim:mentionsumls-concept:C0521009lld:lifeskim
pubmed-article:10438903lifeskim:mentionsumls-concept:C1367307lld:lifeskim
pubmed-article:10438903lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:10438903lifeskim:mentionsumls-concept:C0034790lld:lifeskim
pubmed-article:10438903lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:10438903lifeskim:mentionsumls-concept:C0206527lld:lifeskim
pubmed-article:10438903lifeskim:mentionsumls-concept:C1306235lld:lifeskim
pubmed-article:10438903lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:10438903lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:10438903lifeskim:mentionsumls-concept:C0152060lld:lifeskim
pubmed-article:10438903lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:10438903lifeskim:mentionsumls-concept:C0205154lld:lifeskim
pubmed-article:10438903pubmed:issue4lld:pubmed
pubmed-article:10438903pubmed:dateCreated1999-9-9lld:pubmed
pubmed-article:10438903pubmed:abstractTextRecent data show that TCR/CD3 stimulation induces activation of Stat5 in murine T cells. Here, we show that CD3 ligation by mAb and Staphylococcal enterotoxin (SE) induce a rapid, gradually accumulating, long-lasting tyrosine, and serine phosphorylation of Stat3 (but not Stat5) in allogen-specific human CD4+ T cell lines. In contrast, IL-2 induces a rapid and transient tyrosine and serine phosphorylation of Stat3. Compared with IL-2, CD3 ligation induces a delayed Stat3 binding to oligonucleotide probes from the ICAM-1 and IL-2R alpha promoter. CD3-mediated activation of Stat3 is almost completely inhibited by a Src kinase inhibitor (PP1), whereas IL-2-induced Stat3 activation is unaffected. In conclusion, we show that CD3 ligation by mAb and SE triggers a rapid, PP1-sensitive tyrosine and serine phosphorylation of Stat3 in human CD4+ T cells. Moreover, we provide evidence that TCR/CD3 and IL-2 induce Stat3 activation via distinct signaling pathways.lld:pubmed
pubmed-article:10438903pubmed:languageenglld:pubmed
pubmed-article:10438903pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438903pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10438903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10438903pubmed:statusMEDLINElld:pubmed
pubmed-article:10438903pubmed:monthAuglld:pubmed
pubmed-article:10438903pubmed:issn0022-1767lld:pubmed
pubmed-article:10438903pubmed:authorpubmed-author:RöpkeCClld:pubmed
pubmed-article:10438903pubmed:authorpubmed-author:SvejgaardAAlld:pubmed
pubmed-article:10438903pubmed:authorpubmed-author:NielsenMMlld:pubmed
pubmed-article:10438903pubmed:authorpubmed-author:GeislerCClld:pubmed
pubmed-article:10438903pubmed:authorpubmed-author:OdumNNlld:pubmed
pubmed-article:10438903pubmed:authorpubmed-author:NissenM HMHlld:pubmed
pubmed-article:10438903pubmed:authorpubmed-author:GerwienJJlld:pubmed
pubmed-article:10438903pubmed:authorpubmed-author:LabudaTTlld:pubmed
pubmed-article:10438903pubmed:issnTypePrintlld:pubmed
pubmed-article:10438903pubmed:day15lld:pubmed
pubmed-article:10438903pubmed:volume163lld:pubmed
pubmed-article:10438903pubmed:ownerNLMlld:pubmed
pubmed-article:10438903pubmed:authorsCompleteYlld:pubmed
pubmed-article:10438903pubmed:pagination1742-5lld:pubmed
pubmed-article:10438903pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:meshHeadingpubmed-meshheading:10438903...lld:pubmed
pubmed-article:10438903pubmed:year1999lld:pubmed
pubmed-article:10438903pubmed:articleTitleCutting edge: TCR stimulation by antibody and bacterial superantigen induces Stat3 activation in human T cells.lld:pubmed
pubmed-article:10438903pubmed:affiliationInstitute of Medical Microbiology and Immunology, Institute for Medical Anatomy, University of Copenhagen, Denmark.lld:pubmed
pubmed-article:10438903pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10438903pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10438903lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10438903lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10438903lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10438903lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10438903lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10438903lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10438903lld:pubmed